Skip to main content
    B

    Biogen Inc (BIIB)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $251.65
    -1.75 (-0.69%)

    Market Cap: $37.46B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Biogen Inc (BIIB) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Biogen are Bristol-Myers Squibb Company (BMY), Amgen (AMGN) and GSK (GSK). Biogen trades at 21.4x earnings, against a median of 14.5x for the 8 of these companies with a P/E. By market cap, Biogen ranks 10th of the 13 companies on this page; AbbVie (ABBV) is the largest at $521.50B.

    Peer Comparison

    BIIB's ROIC of 1.3% is below the peer median of 7.6%, and its revenue growth of 10.6% is above the median of 8.9%. It pays no dividend, against a peer median yield of 2.26%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Biogen (BIIB)$37.46B21.4x3.6x3.4%1.3%10.6%0.00%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    BeOne Medicines AG (ONC)$47.58B50.0x18.7x13.9%7.5%33.8%0.00%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    BridgeBio Pharma Inc (BBIO)$15.25BN/A16.0x-59.8%-33.0%192.6%0.00%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    Neurocrine Biosciences Inc (NBIX)$16.94B18.4x4.5x19.0%N/A41.2%0.00%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Grifols SA ADR (GRFS)$5.91B9.9x0.7x6.4%7.6%9.4%1.08%
    Peer median$122.90B14.5x4.1x13.4%7.6%8.9%2.26%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Biogen, ranked by how closely their business, size, sector and industry match. The largest group, 9 of the 12, is in Drug Manufacturers - General; the other 3 span 2 industries.

    CompanyAboutPeers
    Bristol-Myers Squibb Company (BMY)Drug Manufacturers - General
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Amgen Inc (AMGN)Drug Manufacturers - General
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors
    GSK plc (GSK)Drug Manufacturers - General
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    BeOne Medicines AG (ONC)Biotechnology
    BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe...
    ONC competitors
    Sanofi ADR (SNY)Drug Manufacturers - General
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    Pfizer Inc (PFE)Drug Manufacturers - General
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    BridgeBio Pharma Inc (BBIO)Biotechnology
    BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases.
    BBIO competitors
    Gilead Sciences Inc (GILD)Drug Manufacturers - General
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    Novo Nordisk A/S (NVO)Drug Manufacturers - General
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    Neurocrine Biosciences Inc (NBIX)Drug Manufacturers - Specialty & Generic
    Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological...
    NBIX competitors
    AbbVie Inc (ABBV)Drug Manufacturers - General
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors
    Grifols SA ADR (GRFS)Drug Manufacturers - General
    Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives.
    GRFS competitors

    Frequently Asked Questions About BIIB

    Who are Biogen's main competitors?

    The companies most similar to Biogen include Bristol-Myers Squibb Company (BMY), Amgen (AMGN), GSK (GSK), BeOne Medicines AG (ONC) and Sanofi ADR (SNY), listed from the closest match.

    Who is Biogen's biggest competitor?

    AbbVie (ABBV) is the largest of the similar companies at $521.50B; Bristol-Myers Squibb Company (BMY) is the closest match by business profile, size, sector and industry.

    How does BIIB stock compare with its competitors?

    BIIB's P/E is 21.4x against a peer median of 14.5x; its P/S is 3.6x against a peer median of 4.1x; its net margin is 3.4% against a peer median of 13.4%.

    Which of Biogen's competitors pays a higher dividend?

    Biogen pays no dividend. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), GSK (GSK), AbbVie (ABBV), Amgen (AMGN), Gilead Sciences (GILD) and Grifols SA ADR (GRFS) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is Biogen bigger than its competitors?

    No. Biogen is 10th by market cap among the 13 companies on this page; the largest is AbbVie (ABBV) at $521.50B.